MedTrace Logo

AttraX® Putty vs. Autograft in XLIF®

NCT02250248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-12-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the clinical success of AttraX Putty as a bone graft substitute for autograft in XLIF procedures.

Conditions

  • Degenerative Conditions of the Lumbar Spine

Interventions

BIOLOGICAL

AttraX Putty

OTHER

Iliac Crest Bone Graft (ICBG)

Sponsors & Collaborators

  • NuVasive

    lead INDUSTRY

Principal Investigators

  • Cristiano M Menezes, M.D. · Lifecenter to Mater Dei Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2021-05-21
Completion
2021-05-21

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02250248 on ClinicalTrials.gov